131 related articles for article (PubMed ID: 36416121)
1. Stability-Indicating RP-HPLC Method Development and Validation for Eltrombopag Olamine in the Presence of Impurities and Degradation Products. Robustness by Design of Expert Software.
Dandabattina R; Subramanian VB; Merugu KS; SharathBabu H; Katari NK; Kowtharapu LP
J AOAC Int; 2023 Mar; 106(2):267-275. PubMed ID: 36416121
[TBL] [Abstract][Full Text] [Related]
2. Quantification of Drospirenone- and Ethinyl Estradiol-Related Impurities in a Combined Pharmaceutical Dosage Form by a Chromatography Method With a QbD Robustness Study.
Chinta SR; Chintala V; Nandimalla V; Ch R; Ediga SG; Kowtharapu LP; Katari NK
J AOAC Int; 2024 Jan; 107(1):31-39. PubMed ID: 37758265
[TBL] [Abstract][Full Text] [Related]
3. Green Liquid Chromatography Method for the Determination of Related Substances Present in Olopatadine HCl Nasal Spray Formulation, Robustness by Design Expert.
Kowtharapu LP; Katari NK; Sandoval CA; Muchakayala SK; Rekulapally VK
J AOAC Int; 2022 Sep; 105(5):1247-1257. PubMed ID: 35686891
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
[TBL] [Abstract][Full Text] [Related]
5. Stability-indicating RP-HPLC method development and validation for determination of nine impurities in apixaban tablet dosage forms. Robustness study by quality by design approach.
Subramanian VB; Katari NK; Dongala T; Jonnalagadda SB
Biomed Chromatogr; 2020 Jan; 34(1):e4719. PubMed ID: 31634417
[TBL] [Abstract][Full Text] [Related]
6. Stability-indicating reversed-phase-HPLC method development and validation for sacubitril/valsartan complex in the presence of impurities and degradation products: Robustness by quality-by-design approach.
Subramanian VB; Katari NK; Ponnam V; Konduru N; Dongala T; Marisetti VM; Vyas G
Biomed Chromatogr; 2022 Jan; 36(1):e5240. PubMed ID: 34486750
[TBL] [Abstract][Full Text] [Related]
7. QbD-Based Development and Validation of Novel Stability-Indicating Method for the Assay and Dissolution of Garenoxacin in Garenoxacin Tablets.
Azhakesan A; Kuppusamy S
J AOAC Int; 2022 Mar; 105(2):370-378. PubMed ID: 34894249
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a reversed-phase HPLC method for simultaneous analysis of butylhydroxyanisol, simvastatin and its impurities in tablet dosage forms.
El Karbane M; Azougagh M; Amood A L-Kamarany M; Bouchafra H; Cherrah Y; Bouklouze A
Ann Pharm Fr; 2014 Jul; 72(4):244-55. PubMed ID: 24997886
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of apalutamide-related substances method in solid dosage forms using HPLC.
Bandaru LGR; Konduru N; Kowtharapu LP; Regulagadda S; Kanuparthy PR; Gundla R
Biomed Chromatogr; 2023 Apr; 37(4):e5576. PubMed ID: 36573285
[TBL] [Abstract][Full Text] [Related]
10. QBD-driven HPLC method of eltrombopag olamine: Degradation pathway proposal, structure elucidation, and in silico toxicity prediction.
Jayagopal B; Murugesh S
J Pharm Biomed Anal; 2021 Sep; 203():114231. PubMed ID: 34225039
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a stability-indicating RP-HPLC method for the determination of fifteen impurities in rivaroxaban.
Rao W; Li L; Zhang C; Zheng J; Fan X; Luan B; Sun J; Qiu M; Wu S; Li Y; Wang Z
J Pharm Biomed Anal; 2023 May; 228():115325. PubMed ID: 36921446
[TBL] [Abstract][Full Text] [Related]
12. Stability-indicating HPLC method development and validation of rivaroxaban impurities and identification of forced degradation products using LC-MS/MS.
Cholleti V; Ravindra Kumar Y; Pasula A; Surya PRP
Biomed Chromatogr; 2022 Sep; 36(9):e5424. PubMed ID: 35697473
[TBL] [Abstract][Full Text] [Related]
13. Quality by design (QbD) based development and validation of an HPLC method for amiodarone hydrochloride and its impurities in the drug substance.
Karmarkar S; Yang X; Garber R; Szajkovics A; Koberda M
J Pharm Biomed Anal; 2014 Nov; 100():167-174. PubMed ID: 25168215
[TBL] [Abstract][Full Text] [Related]
14. A validated stability-indicating reversed-phase-HPLC method for dipyridamole in the presence of degradation products and its process-related impurities in pharmaceutical dosage forms.
Mallavarapu R; Katari NK; Dongala T; Rekulapally VK; Marisetti VM; Vyas G
Biomed Chromatogr; 2022 Jan; 36(1):e5247. PubMed ID: 34541698
[TBL] [Abstract][Full Text] [Related]
15. Favipiravir (SARS-CoV-2) degradation impurities: Identification and route of degradation mechanism in the finished solid dosage form using LC/LC-MS method.
Vemuri DK; Gundla R; Konduru N; Mallavarapu R; Katari NK
Biomed Chromatogr; 2022 Jun; 36(6):e5363. PubMed ID: 35292997
[TBL] [Abstract][Full Text] [Related]
16. User-Friendly HPLC Method Development and Validation for Determination of Enalapril Maleate and Its Impurities in Enalapril Tablets.
Koppala S; Ranga Reddy V; Anireddy JS
J Chromatogr Sci; 2017 Nov; 55(10):979-988. PubMed ID: 28985272
[TBL] [Abstract][Full Text] [Related]
17. Development of a simple and stability-indicating RP-HPLC method for determining olanzapine and related impurities generated in the preparative process.
Cui D; Li Y; Lian M; Yang F; Meng Q
Analyst; 2011 Aug; 136(15):3149-56. PubMed ID: 21695344
[TBL] [Abstract][Full Text] [Related]
18. Stability-indicating method development and validation for quantitative estimation of assay and organic impurities of antiviral drug baloxavir marboxil in drug substance and pharmaceutical dosage form using HPLC and LC-MS methods.
Nagulancha BR; Lakka NS; Vandavasi KR
Biomed Chromatogr; 2023 Aug; 37(8):e5644. PubMed ID: 37052118
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a stability indicating HPLC method for organic impurities of erythromycin stearate tablets.
Jeelani S; Soukhova N
J Pharm Biomed Anal; 2021 Feb; 195():113858. PubMed ID: 33388642
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous Estimation of Escitalopram and Clonazepam in Tablet Dosage Forms Using HPLC-DAD Method and Optimization of Chromatographic Conditions by Box-Behnken Design.
Foudah AI; Alshehri S; Shakeel F; Alqarni MH; Aljarba TM; Alam P
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
